Downloading...
Download

Medicine

Walk This Way...This S. Korean company focuses on treatment of cystic fibrosis and chronic kidney disease, et al. Future Medicine, Limited. Godspeed to this company as they search for cures for primary biliary cirrhosis; colorectal, prostate, and lung cancers and rheumatoid arthritis, et al. They target metabolic cancers, inflammatory and autoimmune diseases, to produce anticancer drugs, anti-fibrotics and antiviral remedies. Not only persistent, but painful diseases, as well. Who on earth wouldn't want this company to succeed ? Selling Volume has completely Dried-up and the stock is in the process of setting Higher-Lows. MACD, StochasticsRSI, Rate-of-Change, and %r are all additive tenets of confirmation for the astute and intrepid investor. Go Long.... it's at the 20... the 10... the 5... and Touchdown
KRX:341170Long
by sofearnot
Is Gene Editing's Investment Promise Within Reach?CRISPR Therapeutics stands at the vanguard of the gene editing revolution, transitioning into a commercial-stage biopharmaceutical entity following the landmark approval of CASGEVY. This first-of-its-kind gene editing treatment targets sickle cell disease and beta-thalassemia, validating the transformative potential of CRISPR-Cas9 technology and signaling the dawn of a new medical era. CASGEVY's market entry provides critical proof of concept, paving the way for broader gene editing applications in treating genetic disorders. Despite this scientific triumph, CASGEVY's commercial launch faces immediate hurdles, primarily its high cost and complex administration, contributing to slow initial sales. While development partner Vertex Pharmaceuticals reports the revenue, CRISPR receives a profit share. The company currently operates at a loss, with operating expenses significantly exceeding revenue, primarily from grants. However, a robust cash reserve provides financial stability as CRISPR pursues an ambitious pipeline targeting widespread diseases like cancer, diabetes, and cardiovascular conditions, alongside its commercial efforts with CASGEVY. The intellectual property landscape remains dynamic, marked by ongoing patent disputes over the foundational CRISPR-Cas9 technology, which could influence future licensing and competition. Simultaneously, CRISPR Therapeutics contributes to advancements in personalized medicine and delivery systems. A notable achievement includes the rapid development and delivery of a personalized mRNA-based CRISPR therapy for a rare metabolic disorder using lipid nanoparticles, demonstrating a potential model for swift, patient-specific treatments and highlighting the crucial role of advanced delivery technologies in expanding gene editing's therapeutic reach. For investors, CRISPR Therapeutics presents a high-risk, high-reward opportunity. The stock has experienced volatility, reflecting current unprofitability and market conditions. Yet, strong institutional ownership and optimistic analyst ratings underscore confidence in the long-term potential. The company's deep pipeline and foundational technology position it for significant future growth if clinical programs succeed and commercial adoption of its therapies expands, suggesting that for those with a long-term perspective, the promise of gene editing may indeed be within reach.
NASDAQ:CRSPLong
by UDIS_View
2
PFE chart update, Medicine is expensive So essentially, I tried to follow the trends. When doing so, it does form an interesting pattern. It almost looks like a long position chance. It depends on where support lands with price action, and where the trend breakout occurs, as there is a nice gap setup on the charts that puts PFE on a climb and allows it to form a bullish long term trend. Should trend break down past last support and confirm that underside exit, it would probably signal a bearish move is more likely. However, It's a neat setup to watch. good luck Link to other PFE chart will be attached.
NYSE:PFELong
by nicktussing77
1
$OGI - 9-years forecast for the company sharesSo funny and amazing, when you had prepared a long-term vision for a company just 2 days ago, but did not published for a while, and purely by chance get notices, that this company has grown today for almost 250% in some hours. So, nevertheless, this only confirmed, that signals, which were seen are correct and I still can publish my forecast for almost 10 years ahead. I see a huge divergence on 1w timerange and NASDAQ:OGI was able to accumulate a huge potential for the future ascending motion. Being on the bottom and turning around, it has an energy to show perfect plus even from the current values. Of cause, after so enormous jump today, we will observe some kind of correction, but for investors this fact can't be a problem. Good company, fields of the future with a possible nice results. I believe, it will keep on moving to the top. Goal number 1 for 1 year is 4.5 Does not constitute a recommendation. #investing #stocks #idea #forecast #furoreggs Please, subscribe and challenge my point of view )
NASDAQ:OGILong
by furoreggs
2
Ruble developing ground to restructure third world economiesOn the presented chart we have prepared, you can see correlations of Ruble currency with Telecoms, Steel producing, Concrete producing, Land transport and Medicine. As you can see Ruble is building a solid ground to become a back end for the developing world destroyed by conflicts and fist fights. ATR is going down and from the june it shows backward correlation with Ruble. This is good because this means Ruble can rise without volatility. Telecommunications prices are falling after this event. Steel producing showing strange pattern and can be a risk for the Ruble. Concrete producing and transportation developing a good foundation. Transportation industry is still and strong. And medicine industry showing weakness but we see rise in pharmaceuticals profits so we hope this will drag whole venture up.
by UnknownUnicorn462803
2
long $CMPSLooks like the MACD is still heading down but curling up. RSI is bottoming out as it reaches an important level of support. I think the risk reward at the $28 level is optimal. If you have a high risk tolerance, buy now. Shrooms are already decriminalized in Denver and are about to be in Detroit. The TAM which was initially an imaginative number is now becoming real for Compass Pathways. Go long CMPS www.freep.com Looks ready to find a floor and launch on the weekly chart.
NASDAQ:CMPSLong
by EBITDAtiger
2
ISKJ | Fundamental Growth +30%0. Top Russian Medical Genetic company 1. Develop alternative to Sputnik COVID-19 vacine named Betuvax-CoV-2 2. Russian Health Ministry approves clinical trails of Betuvax at September 27 2021. Clinical trails involve 116 volonteer without chronic diseases 3. Forecast release date midwinter 2021. 4. In case of anual vaccination of 1% Russian population target price: 120 RUB 5. In case of anu vaccination rate of 4%, target: 320 RUB 6. Govermental support rate up to +10-20% price impact 7. Lot's of other medical projects that support ISKJ fundamental price at 85 RUB without Betuvax project impact. Target price: 125 RUB
RUS:ABIOLong
by inversion
isr bREAKING OUTMy kid came by and when i was looking at the chart, she said: hey look! a bird! and at the time, there was no bird there was only a small cone I drew for the pennant at the tip of the retracement. I zoom out a little, and noticed, wow you are right the bouncing kind of looks like ahead when you add an eye when I zoomed out more, the chart had a real recollection so I drew it. I think this chart is bullish and this tells tales about the physical element and visual elements of stocks they need to look good, and they project a feeling of motion to people's psyche. the shape, is soothing, smooth, looks organic, (even tho it isn't it is highly manufactured by the shorts) just thought it was interesting to share... I think this stock will go to 8-10$ despite what lots of people are saying in the Weibull chats. This is good lung cancer treatment stock and I think people would be wise to have some. it had a nice-sized green hammer this morning.
ILong
by UnknownUnicorn3570385
Blockchain and it's potential to revolutionize medicine Does anyone remember a project called "folding?" Major Medical Schools and think tanks were soliciting idle computing power from people on the internet toward the greater goal of medical discoveries via the nearly infinite iterations of protein structures and the differences in how they "folded." It seems to me that blockchain technology, with so much math behind each coin and each transaction could be harnessed in the same way. This would likely require altruistic data mining , or the minting of a new coin - a currency with the potential to HELP in ways that go beyond the tabulation , collection and growth of wealth. It would require in all likelihood a very specific algorithm which may or may not already exist. Miracles could be brought into place where thus far only digital currency , gaming , gaming currency , a browser and several other Dapps interesting enough for me to have never heard of them. While people used to DONATE idle computing time/power , in this age I believe it is already recognized that such time and power is a commodity that , sufficient to operate blockchain protocol require ASIC's and massive GPU crammed , dedicated hardware or at the very least my dream gaming rig running specific programs. So..... my question is , when will the amazing mathematical power be applied towards such life saving ends?? Folding as it once was required a good computer and was often used in benchmarking applications. It is time that a coin be minted to incentivize such endeavors , and in my estimation as the blockchain tech surrounding it is applied to these incredibly complex protein structures , and provided that medical breakthroughs are made based upon such an application, that the coin would without question appreciate in value , and re-define what "proof of work" means in the saving of human (and other) lives. Just an idea. Caveat emptor.
BITSTAMP:BTCUSD
by Cryptocautious
Love Terra Tech. and all they've got going!Downward pennant, bearish reversal pattern. Likely to bounce up in the coming month. This company is strategically placed to quickly take advantage of further legalization here in the U.S. and outside as well. Check out their other enriched food products besides cannabis as well! They've got a bunch of hydroponic food farms that are prepped for cannabis when legalized in those areas. Love this company, and going to be holding for a long time. www.terratechcorp.com
TLong
by MonetaryRebel
1
Finding the upcoming support zone and the right time to sell/buyAcadia Pharmaceuticals has shown a downward swing during the past 2 business days or so. Before that it was on a very big run, which on my opinion was due to the high demand and the low buy/sell price. It will soon find support around the 32.67 up to the 38 zone (see the purple channel) based on the past downswing which i just stated. In the very near future it will also go on an run as big as the last one or maybe a little slower, but it will fall out again. In my opinion it would be better to buy soon, sell some when it breaks the channel and then sell more when it reaches the climax of the channel.
NASDAQ:ACAD
by AlbanSako